27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Moderna Inc (NASDAQ:MRNA) shares are trading higher by 3.18% at $165.60 in Friday's pre-market session, recovering some of the losses following the company's first-quarter earnings report.
On Thursday, Moderna reported quarterly earnings of $2.84 per share, which beat the analyst consensus estimate of $2.39. Moderna also reported quarterly sales of $1.90 billion, which missed the analyst consensus estimate of $2.04 billion.
Goldman Sachs analyst Salveen Richter maintains Moderna with a Buy and raises the price target from $206 to $228.
Morgan Stanley maintains Moderna with an Equal-Weight and lowers the price target from $201 to $190.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!